Bart Jan Kullberg

54.0k citations

362 papers · 29.1k indexed · 11 hit papers · h-index 87

Impact in

Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility
Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance

Papers in

Applied Microbiology and Biotechnology 23
- Antibiotic Use and Resistance 23
Infectious Diseases 185
- Antifungal resistance and susceptibility 144

Co-authors: Mihai G. Netea J.W.M. van der Meer Leo A. B. Joosten Maiken Cavling Arendrup Frank L. van de Veerdonk Jos W.M. van der Meer Luis Ostrosky‐Zeichner Peter G. Pappas
Journals: The Journal of Infectious Diseases (21 papers)Clinical Infectious Diseases (18 papers)European Journal of Immunology (16 papers)Infection and Immunity (15 papers)European Journal of Clinical Microbiology & Infectious Diseases (14 papers)
Partner nations: Netherlands United States France

In The Last Decade

Bart Jan Kullberg

355 papers receiving 28.4k citations

Hit Papers

11 papers align trajectories log scale

Invasive candidiasis 2018 · 1.0k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Nature Reviews Disease Primers
2016 The Lancet Infectious Diseases
2015 New England Journal of Medicine
2015 Nature reviews. Immunology
2012 Cell Host & Microbe
2012 Clinical Infectious Diseases
2011 New England Journal of Medicine
2010 Cell Metabolism
2009 Clinical Infectious Diseases
2008 Blood
2007 Nature Reviews Microbiology

Peers

Countries citing papers authored by Bart Jan Kullberg

Since Specialization

Citations

This map shows the geographic impact of Bart Jan Kullberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Jan Kullberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Jan Kullberg more than expected).

Fields of papers citing papers by Bart Jan Kullberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Jan Kullberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Jan Kullberg. The network helps show where Bart Jan Kullberg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bart Jan Kullberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bart Jan Kullberg Line = papers co-authored together Bart Jan Kullberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study Open Forum Infectious Diseases ·George R. Thompson, Haihui Huang, Sizhou Feng, Yunsong Yu, Àlex Soriano, Oliver A. Cornely, Bart Jan Kullberg, Peter G. Pappas, Marin Kollef, José A. Vázquez, Patrick M. Honoré, Laura A. Cox, Matteo Bassetti	2025	0
2	P29 Outcomes by baseline pathogen and susceptibility in the ReSTORE Phase 3 trial of rezafungin once weekly compared with caspofungin once daily in patients with candidaemia and/or invasive candidiasis JAC-Antimicrobial Resistance ·George R. Thompson, Àlex Soriano, Oliver A. Cornely, Bart Jan Kullberg, Marin H. Kollef, José A. Vázquez, Anita Das, Jeffrey B. Locke, Hamed Gad Mohamed Amany, Peter G. Pappas	2023	0
3	A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology Journal of Fungi ·Nico Janssen, Roger J. M. Brüggemann, Monique H. Reijers, Stefanie Henriet, Jaap ten Oever, Quirijn de Mast, Daiana de Jesus da Silva Mendes, Elizabeth de Kort, Bart Jan Kullberg, Mihai G. Netea, Jochem B. Buil, Janette Rahamat–Langendoen, 叶文浩, Eline W. Muilwijk, Jacques F. Meis, Paul E. Verweij, Frank L. van de Veerdonk	2020	10
4	Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient’s perspective: a qualitative study BMJ Open ·Marvin A. H. Berrevoets, Anke Oerlemans, Mirjam Tromp, Bart Jan Kullberg, Jaap ten Oever, Jeroen Schouten, Marlies Hulscher	2018	28
5	Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry BMC Infectious Diseases ·Marvin A. H. Berrevoets, Jaap ten Oever, Tom Sprong, Reinier M. van Hest, 浅井隆二, S. E. Zhu, Jeroen Schouten, Marlies Hulscher, Bart Jan Kullberg	2017	19
6	Intensive care medicine research agenda on invasive fungal infection in critically ill patients Intensive Care Medicine ·Matteo Bassetti, José Garnacho‐Montero, Thierry Calandra, Bart Jan Kullberg, George Dimοpoulos, Élie Azoulay, Arunaloke Chakrabarti, E. Trenkner, Cristóbal León, Luis Ostrosky‐Zeichner, Maurizio Sanguinetti, Jean‐François Timsit, Jiayao Tong, Andrew F. Shorr, Oliver A. Cornely	2017	126
7	CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival Science Translational Medicine ·Muthulekha Swamydas, Ji‐Liang Gao, Timothy J. Break, Melissa D. Johnson, Martin Jaeger, Carlos A. Rodriguez, Jean K. Lim, Gabriel Craft, Amanda L. Collar, Brett G. Fischer, Chyi‐Chia Richard Lee, John R. Perfect, Barbara D. Alexander, Bart Jan Kullberg, Mihai G. Netea, Philip M. Murphy, Michail S. Lionakis	2016	64
8	1,25-dihydroxyvitamin D3 Modulates Cytokine Production Induced by Candida albicans: Impact of Seasonal Variation of Immune Responses The Journal of Infectious Diseases ·Gerhard Jorns, Louis Yi Ann Chai, Hans J. P. M. Koenen, Bart Jan Kullberg, Irma Joosten, André van der Ven, Mihai G. Netea	2010	66
9	SWAB-richtlijn voor de behandeling van invasieve schimmelinfecties Astrid M. L. Oude Lashof, Michel Albarède, Jacques F. Meis, B. Szotowski, J.W. van ’t Wout, Stephanie Natsch, Arthur R. H. van Zanten, Paul E. Verweij, Bart Jan Kullberg	2010	3
10	Drosomycin-Like Defensin, a Human Homologue of Drosophila melanogaster Drosomycin with Antifungal Activity Antimicrobial Agents and Chemotherapy ·Anna Simon, Bart Jan Kullberg, Brian Tripet, Otto C. Boerman, Patrick L.J.M. Zeeuwen, Johanna van der Ven‐Jongekrijg, Paul E. Verweij, Joost Schalkwijk, Robert S. Hodges, Jos W.M. van der Meer, Mihai G. Netea	2008	40
11	Differential Cytokine Production and Toll-Like Receptor Signaling Pathways by Candida albicans Blastoconidia and Hyphae Infection and Immunity ·Chantal A. A. van der Graaf, Mihai G. Netea, Ineke Verschueren, J.W.M. van der Meer, Bart Jan Kullberg	2005	144
12	Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors Journal of Antimicrobial Chemotherapy ·Jeroen Schouten, Marlies Hulscher, Bart Jan Kullberg, LIU Hai-gang, Inge C. Gyssens, J W van der Meer, Richard Grol	2005	37
13	LethalEscherichia coli andSalmonella typhimurium endotoxemia is mediated through different pathways European Journal of Immunology ·Mihai G. Netea, Bart Jan Kullberg, Leo A. B. Joosten, Tom Sprong, Ineke Verschueren, Otto C. Boerman, Franck Amiot, Wim B. van den Berg, J.W.M. van der Meer	2001	39
14	[Optimizing antibiotics policy in the Netherlands. V. SWAB guidelines for perioperative antibiotic prophylaxis. Foundation Antibiotics Policy Team]. PubMed ·M.E.E. van Kasteren, Inge C. Gyssens, Bart Jan Kullberg, Hajo A. Bruining, E.E. Stobberingh, R. J. A. Goris	2000	27
15	[European strategy for control of resistance to antibiotics]. PubMed ·M Sprenger, Luka Ločniškar, Bart Jan Kullberg, Kathryn R. Girard, Dik Mevius, E.E. Stobberingh	1999	1
16	Acute pulmonale histoplasmose als importziekte Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Reinout van Crevel, André van der Ven, Jacques F. Meis, Bart Jan Kullberg	1997	1
17	Glycopeptides: drug selection by means of the soja method European Journal of Hospital Pharmacy ·R. Janknegt, S Abdeldayem Sara, Bart Jan Kullberg, Ellen E. Stobberingh	1997	1
18	Het veranderend patroon van Candida-infecties : andere soorten en meer resistentie Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Bart Jan Kullberg, Andreas Voß	1996	2
19	Schimmelinfecties bij patienten met een gestoorde afweer. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·J.W. van ’t Wout, Bart Jan Kullberg, Jacques F. Meis, Peter Reiss	1995	0
20	Legionella infection with acute renal failure and thrombocytopenia mimicking allograft rejection Transplant International ·Rosane Oliveira de Deus, Bart Jan Kullberg, Jan J. Weening, Leendert A. van Es, Fokko J. van der Woude	1988	2

About Bart Jan Kullberg

Bart Jan Kullberg is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Immunology, Parasitology and Epidemiology, having authored 362 papers that have together received 29.1k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (144 papers), Fungal Infections and Studies (89 papers), Immune Response and Inflammation (73 papers), Vector-borne infectious diseases (31 papers), Inflammasome and immune disorders (29 papers), Pneumonia and Respiratory Infections (24 papers), Antibiotic Use and Resistance (23 papers) and Immunodeficiency and Autoimmune Disorders (23 papers). The work is most often cited by research in Infectious Diseases (13.6k citations), Applied Microbiology and Biotechnology (1.4k citations), Immunology (9.4k citations), Epidemiology (12.7k citations) and Microbiology (1.9k citations). Bart Jan Kullberg has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Mihai G. Netea, J.W.M. van der Meer, Leo A. B. Joosten, Maiken Cavling Arendrup, Frank L. van de Veerdonk, Jos W.M. van der Meer, Luis Ostrosky‐Zeichner, Peter G. Pappas, Neil A. R. Gow and Ineke Verschueren. Their work appears in journals such as The Journal of Infectious Diseases, Clinical Infectious Diseases, European Journal of Immunology, Infection and Immunity and European Journal of Clinical Microbiology & Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact